A scaleable synthesis of fiduxosin

被引:54
作者
Haight, AR [1 ]
Bailey, AE [1 ]
Baker, WS [1 ]
Cain, MH [1 ]
Copp, RR [1 ]
DeMattei, JA [1 ]
Ford, KL [1 ]
Henry, RF [1 ]
Hsu, MC [1 ]
Keyes, RF [1 ]
King, SA [1 ]
McLaughlin, MA [1 ]
Melcher, LM [1 ]
Nadler, WR [1 ]
Oliver, PA [1 ]
Parekh, SI [1 ]
Patel, HH [1 ]
Seif, LS [1 ]
Staeger, MA [1 ]
Wayne, GS [1 ]
Wittenberger, SJ [1 ]
Zhang, WJ [1 ]
机构
[1] Abbott Labs, GPRD Proc Res & Dev, N Chicago, IL 60064 USA
关键词
D O I
10.1021/op049889k
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Fiduxosin (1) has been under development at Abbott Laboratories for the treatment of benign prostatic hyperplasia. A convergent strategy required methodologies for preparation of an enantiomerically pure 3,4-cis-disubstituted pyrrolidine and a 2,3,5-trisubstituted thienopyrazine in a regiospecific manner. A [3+2] cycloaddition of an enantiopure azomethine ylide followed by a diastereoselective crystallization was employed to prepare the benzopyranopyrrolidine in high diastereomeric and enantiomeric purity. Conditions for reduction of an O-aryl lactone susceptible to epimerization were developed, and cyclization of the alcohol/phenol to the ether was accomplished in high yield. The thienopyrazine was prepared by condensation of methyl thioglycolate and a regiospecifically prepared 2-bromo-3-cyano-5-phenylpyrazine. Conditions for effective halogen substitutive deamination to prepare regiospecific trisubstituted pyrazines will be described.
引用
收藏
页码:897 / 902
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2000, US Patent, Patent No. [6046207, 6,046,207]
[2]   Toward the development of α1a adrenergic receptor antagonists [J].
Bock, MG ;
Patane, MA .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 :221-230
[3]   NEW SYNTHESES OF THIENO[2,3-B]PYRAZINE [J].
BOURGUIGNON, J ;
LEMARCHAND, M ;
QUEGUINER, G .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1980, 17 (02) :257-264
[4]   Hetero Diels-Aider-biocatalysis approach for the synthesis of (S)-3-[2-{(methylsulfonyl) oxy}ethoxy]-4-(triphenylmethoxy)-1-butanol methanesulfonate, a key intermediate for the synthesis of the PKC inhibitor LY333531 [J].
Caille, JC ;
Govindan, CK ;
Junga, H ;
Lalonde, J ;
Yao, YM .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2002, 6 (04) :471-476
[5]  
CAINE M, 1976, BRIT J UROL, V48, P255, DOI 10.1111/j.1464-410X.1976.tb03013.x
[6]   A SYNTHESIS OF 1-AZABICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID-ESTERS IN ENANTIOMERICALLY PURE FORM [J].
COTTRELL, IF ;
HANDS, D ;
KENNEDY, DJ ;
PAUL, KJ ;
WRIGHT, SHB ;
HOOGSTEEN, K .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1991, (05) :1091-1097
[7]  
CUNNINGHAM GL, Patent No. 3004058
[8]   Arylmethanesulfonates are convenient latent phenols in the nucleophilic aromatic substitution reaction [J].
Dinsmore, CJ ;
Zartman, CB .
TETRAHEDRON LETTERS, 1999, 40 (21) :3989-3990
[9]   ALKYL NITRITE-METAL HALIDE DEAMINATION REACTIONS .7. SYNTHETIC COUPLING OF ELECTROPHILIC BROMINATION WITH SUBSTITUTIVE DEAMINATION FOR SELECTIVE SYNTHESIS OF MULTIPLY BROMINATED AROMATIC-COMPOUNDS FROM ARYLAMINES [J].
DOYLE, MP ;
VANLENTE, MA ;
MOWAT, R ;
FOBARE, WF .
JOURNAL OF ORGANIC CHEMISTRY, 1980, 45 (13) :2570-2575
[10]   ALKYL NITRITE METAL HALIDE DEAMINATION REACTIONS .2. SUBSTITUTIVE DEAMINATION OF ARYLAMINES BY ALKYL NITRITES AND COPPER(II) HALIDES - DIRECT AND REMARKABLY EFFICIENT CONVERSION OF ARYLAMINES TO ARYL HALIDES [J].
DOYLE, MP ;
SIEGFRIED, B ;
DELLARIA, JF .
JOURNAL OF ORGANIC CHEMISTRY, 1977, 42 (14) :2426-2431